NewsRx

Search our medical news database

HIV/AIDS Therapy

Interleukin-2 ineffective for restoring innate antiviral immunity

Published in Immunotherapy Weekly, June 11th, 2003

The cytokine interleukin (IL)-2 does not restore anti-HIV immune activity in seropositive patients.

Treatment with IL-2 "has frequently resulted in the restoration of CD4 lymphocyte counts but not of virus-specific responses," researchers in France explained.

G.M. Bahr and colleagues at the Pasteur Institute in Lille "reasoned that the absence of reconstituted functional immune parameters could be related to the inability of IL-2 to correct HIV-induced dysfunctions in antigen-presenting cells."

To test this hypothesis, the scientists "used in vitro-differentiated monocyte-derived macrophages (MDMs) and mature dendritic cells...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Immunotherapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook